source
- FDA approves Bristol Myers’ multiple myeloma successorThe FDA has granted accelerated approval for a Bristol Myers Squibb pill called iberdomide for patients with multiple myeloma that’s returned or stopped responding to treatment. Iberdomide is marke…Endpoints · 42m ago↗ source
- Experts warn of deaths linked to Neurocrine's Vykat XR for Prader-Willi syndromeA coalition of specialists in Prader-Willi syndrome has raised serious concerns about the safety profile of Neurocrine Biosciences' drug Vykat XR. The experts point to a series of adverse events,…